214 related articles for article (PubMed ID: 23435427)
21. Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
Zhang Y; Li XJ; He RQ; Wang X; Zhang TT; Qin Y; Zhang R; Deng Y; Wang HL; Luo DZ; Chen G
Int J Oncol; 2018 Jul; 53(1):73-86. PubMed ID: 29658571
[TBL] [Abstract][Full Text] [Related]
22. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-30c suppressed giant-cell tumor of bone cell metastasis and growth via targeting HOXA1.
Ni LY; Zhao JD; Lu YH; Li W; Li BL; Wang XC; Meng QG
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4819-4827. PubMed ID: 29164581
[TBL] [Abstract][Full Text] [Related]
24. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
25. Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach.
Tomida S; Yanagisawa K; Koshikawa K; Yatabe Y; Mitsudomi T; Osada H; Takahashi T
Oncogene; 2007 Jul; 26(31):4600-8. PubMed ID: 17260014
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑577 inhibits the migration and invasion of hepatocellular carcinoma cells by targeting homeobox A1.
Han S; Liu Z; Wang Y; Wang L; Yao B; Guo C; Song T; Tu K; Liu Q
Oncol Rep; 2018 Jun; 39(6):2987-2995. PubMed ID: 29693150
[TBL] [Abstract][Full Text] [Related]
28. A distal enhancer maintaining Hoxa1 expression orchestrates retinoic acid-induced early ESCs differentiation.
Su G; Guo D; Chen J; Liu M; Zheng J; Wang W; Zhao X; Yin Q; Zhang L; Zhao Z; Shi J; Lu W
Nucleic Acids Res; 2019 Jul; 47(13):6737-6752. PubMed ID: 31147716
[TBL] [Abstract][Full Text] [Related]
29. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
31. PRDM14, a putative histone methyl-transferase, interacts with and decreases the stability and activity of the HOXA1 transcription factor.
Draime A; Bridoux L; Belpaire M; Pringels T; Tys J; Rezsohazy R
Biochim Biophys Acta Gene Regul Mech; 2018 May; 1861(5):534-542. PubMed ID: 29471045
[TBL] [Abstract][Full Text] [Related]
32. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
[TBL] [Abstract][Full Text] [Related]
33. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
34. Gab2-mediated signaling promotes melanoma metastasis.
Horst B; Gruvberger-Saal SK; Hopkins BD; Bordone L; Yang Y; Chernoff KA; Uzoma I; Schwipper V; Liebau J; Nowak NJ; Brunner G; Owens D; Rimm DL; Parsons R; Celebi JT
Am J Pathol; 2009 Apr; 174(4):1524-33. PubMed ID: 19342374
[TBL] [Abstract][Full Text] [Related]
35. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells.
Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G
J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion.
Fane ME; Chhabra Y; Spoerri L; Simmons JL; Ludwig R; Bonvin E; Goding CR; Sturm RA; Boyle GM; Haass NK; Piper M; Smith AG
J Invest Dermatol; 2022 Jul; 142(7):1845-1857. PubMed ID: 34958806
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.
Wehbe M; Soudja SM; Mas A; Chasson L; Guinamard R; de Tenbossche CP; Verdeil G; Van den Eynde B; Schmitt-Verhulst AM
PLoS One; 2012; 7(11):e49419. PubMed ID: 23173060
[TBL] [Abstract][Full Text] [Related]
38. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
[TBL] [Abstract][Full Text] [Related]
39. HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner.
Taminiau A; Draime A; Tys J; Lambert B; Vandeputte J; Nguyen N; Renard P; Geerts D; Rezsöhazy R
Nucleic Acids Res; 2016 Sep; 44(15):7331-49. PubMed ID: 27382069
[TBL] [Abstract][Full Text] [Related]
40. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
